Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia

Glucagon and glucagon-like peptide (GLP)-1 are the primary products of proglucagon processing from the pancreas and gut, respectively. Giving dual agonists with glucagon and GLP-1 activity to diabetic, obese mice causes enhanced weight loss and improves glucose tolerance by reduction of food intake...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Tricia M., Field, Benjamin C.T., McCullough, Katherine A., Troke, Rachel C., Chambers, Edward S., Salem, Victoria, Gonzalez Maffe, Juan, Baynes, Kevin C.R., De Silva, Akila, Viardot, Alexander, Alsafi, Ali, Frost, Gary S., Ghatei, Mohammad A., Bloom, Stephen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609580/
https://www.ncbi.nlm.nih.gov/pubmed/23248172
http://dx.doi.org/10.2337/db12-0797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609580/
https://www.ncbi.nlm.nih.gov/pubmed/23248172
http://dx.doi.org/10.2337/db12-0797

Ejemplares similares